Literature DB >> 7488463

Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study.

T E Strandberg1, V V Salomaa, H T Vanhanen, V A Naukkarinen, S J Sarna, T A Miettinen.   

Abstract

OBJECTIVE: To investigate pretrial risk factors and long term mortality (1964-1992) in participants and non-participants of a multifactorial primary prevention trial.
DESIGN: A prospective study among 3313 initially healthy businessmen. During the 1960s (1964 onwards), 3490 healthy male business executives born between 1919 and 1934 participated in voluntary health checks at the Institute of Occupational Health in Helsinki. From that period cardiovascular disease (CVD) risk factors were available in 3313 men. In the beginning of the 1970s these men were invited to join a multifactorial primary prevention trial of CVD. Six groups were formed: (I) healthy participants in a high risk intervention group (n = 612), and (II) their randomised control group (n = 610); (III) a non-participant low risk group (n = 593); (IV) an excluded group with signs of CVD (n = 563); (V) a refused group (n = 867); and (VI) dead (n = 68). Groups I and II participated in the five year prevention trial which started in 1974. Other groups were followed up through registers, with no personal contact. MEASUREMENTS: Cardiovascular risk factors during the 1960s. Mortality follow up using national registers up to 31 December, 1992. MAIN
RESULTS: Baseline risk factors were lowest in the low risk group, highest in the excluded group, intermediate and comparable in other groups. Eighteen-year (1974-1992) mortality (per 1000) was 79.3, 106.6, 155.2, 179.9, and 259.3 in the low risk, control, intervention, refused, and excluded groups, respectively (P < 0.001). In the whole population of 3313 men, the 28-year (1964-1992) total (n = 577) and coronary deaths (n = 199) were significantly predicted by smoking, blood pressure, and cholesterol; cancer deaths (n = 163) by smoking only; and violent deaths (n = 83) by none of the risk factors. One-hour postload glucose was significantly associated with total mortality in the intervention group only. When the intervention and control groups were included in the same model, the effect of group on total mortality tended to be dependent on the 1 h blood glucose value (P = 0.06 for the group by 1 h glucose interaction term).
CONCLUSION: The traditional risk factors (smoking, blood pressure, and cholesterol) are significantly associated with 28-year mortality in this high social class population with previous health education. Conversely, a "clustering" of low risk factors predicted low total, coronary, and cancer mortality. The findings on 1 h blood glucose suggest that factors related to glucose tolerance explain in part the excess mortality in the intervention group compared with the control group.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488463      PMCID: PMC484055          DOI: 10.1136/hrt.74.4.449

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  26 in total

1.  Serum cholesterol and 25-year incidence of and mortality from myocardial infarction and cancer. The Zutphen Study.

Authors:  D Kromhout; E B Bosschieter; M Drijver; C de Lezenne Coulander
Journal:  Arch Intern Med       Date:  1988-05

2.  The latest report from Finland. A lesson in expectations.

Authors:  O Paul; C H Hennekens
Journal:  JAMA       Date:  1991-09-04       Impact factor: 56.272

3.  Probability of middle-aged men developing coronary heart disease in five years.

Authors:  A Keys; C Aravanis; H Blackburn; F S Van Buchem; R Buzina; B S Djordjevic; F Fidanza; M J Karvonen; A Menotti; V Puddu; H L Taylor
Journal:  Circulation       Date:  1972-04       Impact factor: 29.690

4.  Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality.

Authors:  T A Miettinen; J K Huttunen; V Naukkarinen; T Strandberg; S Mattila; T Kumlin; S Sarna
Journal:  JAMA       Date:  1985-10-18       Impact factor: 56.272

5.  Glucose tolerance and blood pressure: long term follow up in middle aged men.

Authors:  V V Salomaa; T E Strandberg; H Vanhanen; V Naukkarinen; S Sarna; T A Miettinen
Journal:  BMJ       Date:  1991-03-02

6.  Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.

Authors:  M F Muldoon; S B Manuck; K A Matthews
Journal:  BMJ       Date:  1990-08-11

7.  Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.

Authors:  Z Chen; R Peto; R Collins; S MacMahon; J Lu; W Li
Journal:  BMJ       Date:  1991-08-03

8.  Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes.

Authors:  E Vartiainen; P Puska; J Pekkanen; J Tuomilehto; J Lönnqvist; C Ehnholm
Journal:  BMJ       Date:  1994-08-13

9.  Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men.

Authors:  T E Strandberg; V V Salomaa; V A Naukkarinen; H T Vanhanen; S J Sarna; T A Miettinen
Journal:  JAMA       Date:  1991-09-04       Impact factor: 56.272

10.  Plasma cholesterol concentration and mortality. The Whitehall Study.

Authors:  G D Smith; M J Shipley; M G Marmot; G Rose
Journal:  JAMA       Date:  1992-01-01       Impact factor: 56.272

View more
  20 in total

1.  Why heart disease mortality is low in France: the time lag explanation.

Authors:  M Law; N Wald
Journal:  BMJ       Date:  1999-05-29

2.  Effect on trend estimates of the difference between survey respondents and non-respondents: results from 27 populations in the WHO MONICA Project.

Authors:  Hanna Tolonen; Annette Dobson; Sangita Kulathinal
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  Outcomes for patients with the same disease treated inside and outside of randomized trials: a systematic review and meta-analysis.

Authors:  Natasha Fernandes; Dianne Bryant; Lauren Griffith; Mohamed El-Rabbany; Nisha M Fernandes; Crystal Kean; Jacquelyn Marsh; Siddhi Mathur; Rebecca Moyer; Clare J Reade; John J Riva; Lyndsay Somerville; Neera Bhatnagar
Journal:  CMAJ       Date:  2014-09-29       Impact factor: 8.262

Review 4.  Multiple risk factor interventions for primary prevention of coronary heart disease.

Authors:  S Ebrahim; A Beswick; M Burke; G Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

5.  Total and cause specific mortality among participants and non-participants of population based health surveys: a comprehensive follow up of 54 372 Finnish men and women.

Authors:  Pekka Jousilahti; Veikko Salomaa; Kari Kuulasmaa; Matti Niemelä; Erkki Vartiainen
Journal:  J Epidemiol Community Health       Date:  2005-04       Impact factor: 3.710

Review 6.  Systematic review to determine whether participation in a trial influences outcome.

Authors:  Gunn Elisabeth Vist; Kåre Birger Hagen; P J Devereaux; Dianne Bryant; Doris Tove Kristoffersen; Andrew David Oxman
Journal:  BMJ       Date:  2005-05-21

7.  Hypertension and risk of death from external causes in the Physicians' Health Study enrollment cohort.

Authors:  Paul D Terry; Robert J Glynn; Julie E Buring; Howard D Sesso
Journal:  Int J Public Health       Date:  2010-09-11       Impact factor: 3.380

8.  Increased Mortality Despite Successful Multifactorial Cardiovascular Risk Reduction in Healthy Men: 40-Year Follow-Up of the Helsinki Businessmen Study Intervention Trial.

Authors:  T E Strandberg; K Räikkönen; V Salomaa; A Strandberg; H Kautiainen; M Kivimäki; K Pitkälä; J Huttunen
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

9.  A comparison of mortality rates in three prospective studies from Copenhagen with mortality rates in the central part of the city, and the entire country. Copenhagen Center for Prospective Population Studies.

Authors:  L B Andersen; J Vestbo; K Juel; A M Bjerg; N Keiding; G Jensen; H O Hein; T I Sørensen
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

10.  Non-response to baseline, non-response to follow-up and mortality in the Whitehall II cohort.

Authors:  Jane E Ferrie; Mika Kivimäki; Archana Singh-Manoux; Alison Shortt; Pekka Martikainen; Jenny Head; Michael Marmot; David Gimeno; Roberto De Vogli; Marko Elovainio; Martin J Shipley
Journal:  Int J Epidemiol       Date:  2009-03-05       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.